Two medicines, side by side
Azelastine vs mometasone
Azelastine and mometasone are both labeled for allergies. Drugs@FDA records approvals of azelastine since 1996 and of mometasone since 1987. Pharmacies paid $0.273 per mL (Azelastine 0.1% (137 mcg) spry) and $0.354 per gram (Mometasone furoate 0.1% cream) (NADAC, October 7, 2026). In FDA's classes, azelastine is a histamine-1 receptor antagonist and mometasone a corticosteroid.
Check it at the source: the azelastine FDA label on DailyMed (effective December 4, 2025); the mometasone FDA label on DailyMed (effective August 19, 2026).
Highlights of the azelastine record
Azelastine (Astepro) · label of December 4, 2025
Used for
From the label: indicationsUses temporarily relieves these symptoms due to hay fever or other upper respiratory allergies: nasal congestion runny nose sneezing itchy nose
On the market
- Earliest approval on file
- November 1, 1996
- Generic labelers
- 22 labelers
- Pharmacy cost
- $0.273 per mL
Supply and safety
- Shortage
- No current entry
- Recalls
- 3
Highlights of the mometasone record
Mometasone (Allergy) · label of August 19, 2026
Used for
From the label: indicationstemporarily relieves these symptoms of hay fever or other upper respiratory allergies: • nasal congestion • runny nose • sneezing • itchy nose
On the market
- Earliest approval on file
- April 30, 1987
- Generic labelers
- 16 labelers
- Pharmacy cost
- $0.354 per gram
Supply and safety
- Shortage
- No current entry
- Recalls
- 8
Source: FDA drug labels via openFDA (Azelastine label of December 4, 2025, Mometasone label of August 19, 2026); NDC Directory, Drugs@FDA, NADAC, FDA shortages and recalls (October 8, 2026)
How do azelastine and mometasone differ on the record?
In FDA's classes, azelastine is a histamine-1 receptor antagonist and mometasone a corticosteroid.
Generics: azelastine since 2009; mometasone since 2002 (Drugs@FDA).
| Azelastine | Mometasone | |
|---|---|---|
| Labeled for | Allergies | Allergies, Asthma |
| Pharmacologic class | Histamine-1 Receptor Antagonist | Corticosteroid |
| How it works (label) | n/a | n/a |
| Half-life (label) | n/a | n/a |
| Earliest approval on file (Drugs@FDA) | November 1, 1996 | April 30, 1987 |
| First generic approved | April 30, 2009 | March 18, 2002 |
| Generic labelers (NDC) | 22 labelers | 16 labelers |
| Pharmacy cost (NADAC, each one's most listed form; strengths differ) | $0.273 per mL (Azelastine 0.1% (137 mcg) spry) | $0.354 per gram (Mometasone furoate 0.1% cream) |
| 12-month price change | -4% | -3% |
| Boxed warning | No | No |
| Shortage now | No current entry | No current entry |
| Recalls recorded | 3 | 8 |
| FAERS reports (a report is not proof of cause; counts follow how widely a medicine is used) | 18,108 | 41,531 |
| DEA schedule | none | none |
Source: Drugs@FDA, FDA NDC Directory, CMS NADAC of October 7, 2026, FDA shortages and recalls, FAERS via openFDA (FDA files October 8, 2026)
What next?
- Alternatives to azelastine
- every medicine labeled for the same conditions